SOLACI-CACI 2021 | SELUTION SLR DEB – Changing the Treatment Paradigm for Complex Lesions – Medalliance Symposium

✔️ MEDALLIANCE Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: SELUTION SLR DEB – Changing the Treatment Paradigm for Complex Lesions.

👨‍🏫 Program:

  • 00:06 – Introducción – Dr. Alexandre Abizaid
  • 02:07 – When and why to use DEBs and the importance of sustained limus release – Dr. Ron Waksman
  • 25:17 – SELUTION SLR Clinical Data Overview – Dr. Ricardo Costa
  • 33:26 – Real World Case Experience: a new treatment strategy with sustained limus release DEB – Dr. Florim Cuculi

👉 Moderator: Dr. Alexandre Abizaid.
👉 Speakers: Dr. Aníbal Damonte – Dr. Gastón Dussaillant – Dr. Marco Wainstein.

This event took place on August 3rd, 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...